Monoclonal antibodies can be gamechanger for India: Experts
Monoclonal antibody drug production in India at reasonable price could be a game changer for the country in its fight against COVID-19, said Dr Arvinder S Soi
Stay updated with breaking news from Arvinders Soin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Monoclonal antibody drug production in India at reasonable price could be a game changer for the country in its fight against COVID-19, said Dr Arvinder S Soi
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.
India News: NEW DELHI: Last week, an 84-year-old man from Haryana was administered the "famous" anti-Covid cocktail that was also given to former US President Don.
Date Time Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India – one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in cr...